Express Scripts announces CEO’s retirement, successor

ST. LOUIS — Express Scripts  on Thursday announced the retirement of George Paz as CEO, effective after the company's annual stockholders meeting in May 2016. Company President Tim Wentworth will succeed Paz.

Paz will remain on the board as non-executive chairman following his retirement, and Thomas MacMahon will continue as lead independent director, according to the company.

"I am honored to lead Express Scripts, a vital healthcare company powered by 30,000 people who are passionate about delivering the best pharmacy care to patients," Wentworth said. "Every day, we put medicine within reach of 85 million people by uniquely combining innovative solutions, specialized care and focused, industry-leading scale. I am excited about our future and how we will continue to change health care, while delivering better value, service and care to clients and patients."

Wentworth, who currently reports directly to Paz, was named president in February 2014. He is responsible for sales and account management, information technology, operations, research and new solutions, home delivery and specialty pharmacies, and supply chain management.

Wentworth previously served as SVP and president of sales and account management, with responsibility for Express Scripts' core sales and account management teams, including employer groups, health plans, and new sales.

Wentworth joined Express Scripts following the company's merger with Medco Health Solutions in April 2012, the company said. He previously led Medco's employer and accounts organizations for nearly 14 years, and also served as president and CEO of Accredo, the company's specialty pharmacy. Before joining Medco, Wentworth spent five years at Mary Kay, where he served as SVP of human resources and then as president of the international division. He had a nine-year career in human resources management at PepsiCo.